Seeking Alpha

Momenta Pharmaceuticals (MNTA) says partner Sandoz confirmed the launch of a generic version of...

Momenta Pharmaceuticals (MNTA) says partner Sandoz confirmed the launch of a generic version of its Lovenox blood thinner under an agreement that features a hybrid royalty-profit sharing plan. MNTA -10.5% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector